The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 10, Pages 3145
Publisher
MDPI AG
Online
2020-09-29
DOI
10.3390/jcm9103145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Diastology Guidelines: Evolution, Validation and Impact on Clinical Practice
- (2019) Sandhir B. Prasad et al. Heart Lung and Circulation
- CMR in the Evaluation of Diastolic Dysfunction and Phenotyping of HFpEF
- (2019) Mohammed A. Chamsi-Pasha et al. JACC-Cardiovascular Imaging
- A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction
- (2018) Yogesh N. V. Reddy et al. CIRCULATION
- Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients wi
- (2018) Jan F. Nauta et al. EUROPEAN JOURNAL OF HEART FAILURE
- The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review
- (2018) Milad Baniaamam et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Invasive Validation of the Echocardiographic Assessment of Left Ventricular Filling Pressures Using the 2016 Diastolic Guidelines: Head-to-Head Comparison with the 2009 Guidelines
- (2018) Bhavna Balaney et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Diastolic dysfunction in rheumatoid arthritis patients with low disease activity
- (2018) Bożena Targońska-Stępniak et al. CLINICAL RHEUMATOLOGY
- Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure
- (2017) Ängla Mantel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of the 2016 ASE/EACVI recommendations on the prevalence of diastolic dysfunction in the general population
- (2017) João G Almeida et al. European Heart Journal-Cardiovascular Imaging
- Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection FractionClinical Perspective
- (2016) Masaru Obokata et al. CIRCULATION
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2016) Sherif F. Nagueh et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing
- (2016) A. E. Huis in ’t Veld et al. Netherlands Heart Journal
- Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
- (2016) Peter Willeit et al. Lancet Diabetes & Endocrinology
- Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging
- (2015) Yasuyuki Kobayashi et al. International Journal of Rheumatic Diseases
- Echocardiographic evaluation of diastolic dysfunction in rheumatoid arthritis – a case–control study
- (2015) Abhishek Sharma et al. Modern Rheumatology
- “Inflammation and arterial stiffness in humans”
- (2014) Snigdha Jain et al. ATHEROSCLEROSIS
- Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results : cardiovascular topic
- (2014) Cetin Suha et al. Cardiovascular Journal of Africa
- Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis
- (2014) Ignatios Ikonomidis et al. Circulation-Cardiovascular Imaging
- Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging
- (2014) H. Kobayashi et al. JOURNAL OF RHEUMATOLOGY
- Rheumatoid arthritis and cardiovascular disease
- (2013) Cynthia S. Crowson et al. AMERICAN HEART JOURNAL
- Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
- (2013) Alper M van Sijl et al. ANNALS OF THE RHEUMATIC DISEASES
- NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study
- (2013) Julio C. B. Moraes et al. CLINICAL RHEUMATOLOGY
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases
- (2012) Ľubomír Tomáš et al. CLINICAL RHEUMATOLOGY
- Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide
- (2012) P. J. KOTYLA et al. JOURNAL OF RHEUMATOLOGY
- Diastolic Dysfunction in Rheumatoid Arthritis: A Meta-Analysis and Systematic Review
- (2012) Fawad Aslam et al. ARTHRITIS CARE & RESEARCH
- EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
- (2012) R. M. Lang et al. European Heart Journal-Cardiovascular Imaging
- Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China
- (2011) C. C. Mok et al. ARTHRITIS AND RHEUMATISM
- NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study
- (2010) S. Provan et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2010) S. L. Westlake et al. RHEUMATOLOGY
- Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis
- (2010) Ziyad Al-Aly et al. Translational Research
- Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study
- (2009) M. J. L. Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- B-Type Natriuretic Peptides and Cardiovascular Risk
- (2009) Emanuele Di Angelantonio et al. CIRCULATION
- Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis
- (2009) I Ikonomidis et al. HEART
- When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease
- (2009) Alberto Giannoni et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
- (2008) Peter Libby AMERICAN JOURNAL OF MEDICINE
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More